The emergence of a worrisome coronavirus variant is benefiting shares of vaccine makers Moderna Inc (MRNA), BioNTech (BNTX) and Pfizer.
Moderna shares have jumped 28% since last week when the variant, named Omicron, triggered global alarm. Shares of vaccine partners Pfizer and BioNtech have also climbed over that time, with Pfizer up 6% and U.S. shares of BioNTech jumping 15%, in contrast to a decline in the S&P 500 of 2.5%.
